Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EMEA/Eastern Block To Form Drug Regulation Action Plan In February

Executive Summary

EU regulators and their counterparts from Central and Eastern European countries will meet in Budapest in early February to form an action plan for the European Commission's Pan-European Regulatory Forum (PERF) for pharmaceuticals.

You may also be interested in...



EU Drug Advertising, E-Commerce Working Groups To Be Formed By 2000

The European Commission's Pharmaceutical Committee plans to establish ad hoc working groups on advertising and electronic commerce by late 1999 or early 2000.

EU Drug Advertising, E-Commerce Working Groups To Be Formed By 2000

The European Commission's Pharmaceutical Committee plans to establish ad hoc working groups on advertising and electronic commerce by late 1999 or early 2000.

EU Commission Oversight Of EMEA Will Fall To Finland's Liikanen

European Commission oversight of the European Medicines Evaluation Agency is likely to be directed by Finland's Erkki Liikanen, pending the outcome of European Parliament deliberations on the proposed Prodi commission beginning the week of Aug. 30.

Related Content

UsernamePublicRestriction

Register

PS034913

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel